newsfilter
← Latest News
GlobeNewswire·

Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update

Trudhesa® TRx's Grew 48% in Q2 2022 to Over 13K: Net Product Revenue Increased 59% Over Q1 2022 to $2.8 Million Sales Force Expanded by 50% to Capitalize on Prescription Momentum and Market Opportunity Company Reiterated Prescription Guidance Ran